“If you can make it (promotion) happen, the reward is going to be great, but the risk can be significant,” Sampdoria majority shareholder Joseph Tey tells CNA.
Billionaire backs shake-up at FDA: ex-Enron trader upends drug policy
...
Read moreDetails
